NRIX Nurix Therapeutics, Inc.
NRIX Nurix Therapeutics, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $16.64 · VWAP $19.15 · +32.3% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CFO, Officer + 1 other sold $953.8K, Jul 30–Aug 5
Coverage
1 watchlist
NRIX Price Structure
Loading timeframes…
Peers
Every watchlist NRIX belongs to, members best 30-day change first — NRIX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Nurix reported third-quarter results in a press release dated October 12, 2026: revenue of $673.1M and EPS of $4.73, driven by the upfront payment under its Roche collaboration, with operating income of $559.5M and cash runway extended into 2029 (Markets Insider press-release page; Sci-Tech Today).
full note →Against street estimates
How NRIX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about NRIX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 7 days ago · Oct 16
- Nurix Therapeutics Reports Third Quarter 2026 Financial ...
- Nurix Therapeutics earns $550M in Q3 2026 | NRIX Quarterly ...
- Stock quote & chart | Nurix Therapeutics, Inc.
- Nurix Therapeutics (NRIX) Q3 2026 Earnings Results & Report
- Nurix Therapeutics (NRIX) Stock Price & Overview
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
NRIX research tape
63 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.